Skip to content
Disclosery

GSK plc

Follow

13F filer, CIK 1131399, London, United Kingdom

GSK plc reported $602,220,442 across 13 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 97.52% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001999371-26-017873

Period
2026-06-30
Reported value
$602M
Holdings
13
Top 10 weight
97.52%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001999371-26-017873, largest first. % of portfolio is the value over $602,220,442, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,220,627 shares; 2026Q1: 3,220,627 shares; 2026Q2: 3,220,627 shares 3,220,627$176M29.17%0Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 18,245,691 shares; 2026Q1: 18,245,691 shares; 2026Q2: 18,245,691 shares 18,245,691$106M17.6%0Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 8,550,954 shares; 2026Q1: 8,550,954 shares; 2026Q2: 8,550,954 shares 8,550,954$87.1M14.47%0Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 889,824 shares; 2026Q1: 889,824 shares; 2026Q2: 889,824 shares 889,824$82.8M13.75%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,333,333 shares; 2026Q1: 1,333,333 shares; 2026Q2: 1,333,333 shares 1,333,333$49.7M8.25%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 340,434 shares; 2026Q1: 340,434 shares; 2026Q2: 340,434 shares 340,434$29M4.82%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,512,659 shares; 2026Q1: 1,512,659 shares; 2026Q2: 1,512,659 shares 1,512,659$21.3M3.53%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 9,190,606 shares; 2026Q1: 9,190,606 shares; 2026Q2: 9,190,606 shares 9,190,606$20.3M3.37%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,150,732 shares; 2026Q1: 3,150,732 shares; 2026Q2: 3,150,732 shares 3,150,732$8.92M1.48%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,785,714 shares; 2026Q1: 1,785,714 shares; 2026Q2: 1,785,714 shares 1,785,714$6.54M1.09%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,529,561 shares; 2026Q1: 1,529,561 shares; 2026Q2: 1,529,561 shares 1,529,561$6.49M1.08%0Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,007,583 shares; 2026Q1: 1,007,583 shares; 2026Q2: 1,007,583 shares 1,007,583$5.18M0.86%0Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 271,456 shares; 2026Q1: 271,456 shares; 2026Q2: 271,456 shares 271,456$3.25M0.54%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001999371-26-017873 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001999371-26-017873 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001999371-26-010742 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001999371-26-003198 Quarter ended 2025-12-312026-02-12acceptance time not in the bulk data set